DE69606840D1 - Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung - Google Patents

Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung

Info

Publication number
DE69606840D1
DE69606840D1 DE69606840T DE69606840T DE69606840D1 DE 69606840 D1 DE69606840 D1 DE 69606840D1 DE 69606840 T DE69606840 T DE 69606840T DE 69606840 T DE69606840 T DE 69606840T DE 69606840 D1 DE69606840 D1 DE 69606840D1
Authority
DE
Germany
Prior art keywords
monohydrates
preparation
aminobenzenesulfonic acid
acid derivatives
monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69606840T
Other languages
English (en)
Other versions
DE69606840T2 (de
Inventor
Chika Yamazaki
Tadao Sato
Tatsuo Nagano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of DE69606840D1 publication Critical patent/DE69606840D1/de
Application granted granted Critical
Publication of DE69606840T2 publication Critical patent/DE69606840T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
DE69606840T 1995-12-15 1996-12-14 Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung Expired - Lifetime DE69606840T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32664895 1995-12-15
JP32706895 1995-12-15

Publications (2)

Publication Number Publication Date
DE69606840D1 true DE69606840D1 (de) 2000-04-06
DE69606840T2 DE69606840T2 (de) 2000-10-12

Family

ID=26572248

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69606840T Expired - Lifetime DE69606840T2 (de) 1995-12-15 1996-12-14 Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung

Country Status (9)

Country Link
US (2) US5990113A (de)
EP (1) EP0779283B1 (de)
AT (1) ATE190054T1 (de)
CA (1) CA2192731C (de)
DE (1) DE69606840T2 (de)
DK (1) DK0779283T3 (de)
ES (1) ES2143132T3 (de)
GR (1) GR3033231T3 (de)
PT (1) PT779283E (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192731C (en) * 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
CA2320627C (en) * 1998-02-12 2007-10-30 Mitsubishi Chemical Corporation Medicament for treatment of diastolic dysfunction
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US6586000B2 (en) 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6562368B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
ES2233493T3 (es) * 1999-12-21 2005-06-16 Mitsubishi Pharma Corporation Agentes terapeuticos y/o profilacticos para trastornos del sistema nervioso.
JPWO2002034735A1 (ja) * 2000-10-23 2004-03-04 藤沢薬品工業株式会社 溶媒和物の取得方法及び溶媒和物
WO2002072097A1 (fr) * 2001-03-13 2002-09-19 Mitsubishi Pharma Corporation Remedes et/ou medicaments preventifs pour des cardiopathies ischemiques diabetiques
AR034887A1 (es) * 2001-07-25 2004-03-24 Mitsubishi Pharma Corp Medicamento inhibidor del sistema de intercambio sodio/calcio
CA2455858A1 (en) * 2001-07-30 2003-02-13 Mitsubishi Pharma Corporation Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient
AU2003261815A1 (en) * 2002-08-30 2004-03-19 Mitsubishi Pharma Corporation Inhibitors for excessive accumulation of sodium ion in cells
AU2003261968A1 (en) * 2002-09-06 2004-03-29 Mitsubishi Pharma Corporation Protective agents for transplanted organ
US7067867B2 (en) * 2002-09-30 2006-06-27 Nanosys, Inc. Large-area nonenabled macroelectronic substrates and uses therefor
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
JPWO2005084668A1 (ja) * 2004-03-05 2007-11-29 三菱ウェルファーマ株式会社 虚血性循環器疾患の予防及び／又は治療のための薬剤
US7115971B2 (en) * 2004-03-23 2006-10-03 Nanosys, Inc. Nanowire varactor diode and methods of making same
EP1941554A2 (de) * 2005-06-02 2008-07-09 Nanosys, Inc. Lichtemittierende nanodrähte für die makroelektronik
EP2048138A4 (de) * 2006-07-21 2009-10-28 Mitsubishi Tanabe Pharma Corp Salz oder solvat von 5-methyl-2-(piperazin-1-yl)benzolsulfonsäure
EP2050741A4 (de) * 2006-07-21 2009-10-28 Mitsubishi Tanabe Pharma Corp Kristalliner polymorphismus von 5-methyl-2-(piperazin-1-yl)benzolsulfonsäure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE390654C (de) 1922-03-19 1924-02-24 Paul Lucas Bunsenbrenner fuer fluessige Brennstoffe
GB1450746A (en) * 1974-01-31 1976-09-29 Ici Ltd Tripendioxazine dyestuffs
US4411904A (en) * 1981-05-29 1983-10-25 Warner-Lambert Company Diphenylpropanamines, compositions thereof and use thereof
GB2126598A (en) * 1982-08-16 1984-03-28 Ici Plc Reactive dyestuffs
US5053409A (en) * 1989-03-27 1991-10-01 Mitsubishi Kasei Corporation Aminobenzenesulfonic acid derivatives
JPH0686438B2 (ja) 1989-03-27 1994-11-02 三菱化成株式会社 アミノベンゼンスルホン酸誘導体
JP3083544B2 (ja) 1990-09-27 2000-09-04 三菱化学株式会社 心疾患を予防または治療する薬剤
JP2951476B2 (ja) 1992-03-27 1999-09-20 古河電気工業株式会社 水底布設長尺体の水中引入方法
US5486517A (en) * 1994-05-10 1996-01-23 Warner-Lambert Company Benzimidazoles and imidazopyridines as central nervous system agents
US5457107A (en) * 1994-09-16 1995-10-10 Merck & Co., Inc. Polymorphic form of a tachykinin receptor antagonist
CA2192731C (en) * 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof

Also Published As

Publication number Publication date
CA2192731A1 (en) 1997-06-16
EP0779283B1 (de) 2000-03-01
US5990113A (en) 1999-11-23
US6245767B1 (en) 2001-06-12
DK0779283T3 (da) 2000-06-26
ATE190054T1 (de) 2000-03-15
DE69606840T2 (de) 2000-10-12
ES2143132T3 (es) 2000-05-01
EP0779283A1 (de) 1997-06-18
PT779283E (pt) 2000-08-31
GR3033231T3 (en) 2000-08-31
CA2192731C (en) 2005-09-27

Similar Documents

Publication Publication Date Title
DE69606840D1 (de) Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung
DE69023947D1 (de) Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
ATE40368T1 (de) Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE139232T1 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
FI942076A (fi) Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina
ATE103267T1 (de) 7-substituierte derivate der 3,5-dihydroxyhept-6- insaeure, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte.
ES2113413T3 (es) Derivados antiviricos del acido 2-desoxi-2,3-didehidro alfa-d-neuraminico 4 substituido.
NO810684L (no) Fremgangsmaate ved fremstilling av indanderivater.
DE69418243T2 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE201024T1 (de) Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE3429T1 (de) Paromomycin-derivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammenzetzung.
DE69120699D1 (de) N-Monosubstituierte Cyclopentenylamine, ein Verfahren zu ihrer Herstellung, und ihre Verwendung als Medikament
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
ATE171704T1 (de) Optisch wirksame alkylendioxybenzolderivate und ihre verwendung als arzneimittel
ATE105838T1 (de) 6-fluor-3,5-dihydroxycarbonsäuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische präparate und zwischenprodukte.
DE69007422T2 (de) 1-(4-Aminophenyl)-2-piperidinopropanon-Derivate, Verfahren zu deren Herstellung und therapeutische Verwendung.
FR2703048B1 (fr) Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
AU7971182A (en) Anthranilic acid derivatives
ATE4717T1 (de) Vincaminderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE3295T1 (de) Clavulansaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
FR2373539A1 (fr) Derives de l'acide dithiocarbamique, leur procede de preparation et leur application en medecine veterinaire
DK214884A (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition